Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

The aim of this review is to provide a clinical update on diabetic retinopathy (DR) for the primary care physician. It should be noted, however, that diabetes can impact other sites within the eye ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Geriatrics and Aging. 2008;11(6):333-341. Proliferative diabetic retinopathy is clinically characterized by the growth of new blood vessels that arise from the optic disc and/or retina and ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...

View the latest Vanguard LifeStrategy Moderate Growth Fund;Investor (VSMGX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Scattered storm chances continue Friday in Chicago 02:00. More scattered storms are expected in the Chicago area on Friday in keeping with the trend of recent days, but nothing severe is anticipated.

First patient dosed in Vantage Biosciences' phase 2 study of VX-01 for nonproliferative diabetic retinopathy. Martin David Harp. April 12th 2025. VX01-DR-201, is a phase 2, multi-center, double-masked ...